CASSANDRA GREEN: Open Payments
NPI 1316580657 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,692 in 96 payments from 23 companies in 2025. Trend: 2023 $111 · 2024 $1,506 · 2025 $1,692
Food & beverage: $1,692
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $601 |
| Lilly USA, LLC | 9 | $158 |
| AstraZeneca Pharmaceuticals LP | 7 | $154 |
| Novo Nordisk Inc | 6 | $101 |
| GlaxoSmithKline, LLC. | 5 | $100 |
| Medtronic, Inc. | 5 | $88 |
| Phathom Pharmaceuticals, Inc. | 3 | $74 |
| Exact Sciences Corporation | 3 | $56 |
| Astellas Pharma US Inc | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
Products named: UBRELVY, VRAYLAR, MOUNJARO, QULIPTA, BREZTRI, INTELLIS ADAPTIVESTIM, VOQUEZNA, Ozempic.
Industry payments across IN — which companies pay providers there.
